The landscape of diabetes care is changing with the introduction of GLP-1 patches . These innovative devices offer a potentially less invasive alternative to shots for individuals living with diabetes 2. Such a system deliver a GLP-1 agonist directly through the dermis , avoiding the necessity for regular injections and possibly enhancing patient a